Influx Healthtech Limited (NSE:INFLUX)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Vitamins & Nutrition Products	1.47B	1.05B	999.65M	760.57M	592.02M
Vitamins & Nutrition Products Growth	40.04%	4.89%	31.44%	28.47%	-
Total	1.47B	1.05B	999.65M	760.57M	592.02M
Total Growth	40.04%	4.89%	31.44%	28.47%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2022	FY 2021
Period Ending	Mar 31, 2022	Mar 31, 2021
Export	190.00K
India	591.83M
Total	592.02M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error